Your browser doesn't support javascript.
loading
Microbiota medicine: towards clinical revolution.
Gebrayel, Prisca; Nicco, Carole; Al Khodor, Souhaila; Bilinski, Jaroslaw; Caselli, Elisabetta; Comelli, Elena M; Egert, Markus; Giaroni, Cristina; Karpinski, Tomasz M; Loniewski, Igor; Mulak, Agata; Reygner, Julie; Samczuk, Paulina; Serino, Matteo; Sikora, Mariusz; Terranegra, Annalisa; Ufnal, Marcin; Villeger, Romain; Pichon, Chantal; Konturek, Peter; Edeas, Marvin.
Afiliación
  • Gebrayel P; International Society of Microbiota, Tokyo, Japan.
  • Nicco C; Department Endocrinology, Metabolism and Diabetes, Faculté de Médecine Cochin-Port Royal, Université de Paris, INSERM U1016, Institut Cochin, 24 Rue du Faubourg St Jacques, 75014, Paris, France.
  • Al Khodor S; Laboratory of Excellence GR-Ex, Paris, France.
  • Bilinski J; Maternal and Child Health Department, Research Branch, Sidra Medicine, Doha, Qatar.
  • Caselli E; Medical University of Warsaw, Warsaw, Poland.
  • Comelli EM; University of Ferrara, Ferrara, Italy.
  • Egert M; University of Toronto, Toronto, Canada.
  • Giaroni C; Furtwangen University, Furtwangen, Germany.
  • Karpinski TM; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Loniewski I; Poznan University of Medical Sciences, Poznan, Poland.
  • Mulak A; Pomeranian Medical University, Szczecin, Poland.
  • Reygner J; Wroclaw Medical University, Wroclaw, Poland.
  • Samczuk P; Université Paris Descartes, Paris, France.
  • Serino M; Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.
  • Sikora M; IRSD, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France.
  • Terranegra A; National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
  • Ufnal M; Maternal and Child Health Department, Research Branch, Sidra Medicine, Doha, Qatar.
  • Villeger R; Medical University of Warsaw, Warsaw, Poland.
  • Pichon C; University of Clermont Auvergne, Clermont-Ferrand, France.
  • Konturek P; Center for Molecular Biophysics CNRS UPR 4301, University of Orléans, Orléans, France.
  • Edeas M; Teaching Hospital of the University of Jena, Jena, Germany.
J Transl Med ; 20(1): 111, 2022 03 07.
Article en En | MEDLINE | ID: mdl-35255932
The human gastrointestinal tract is inhabited by the largest microbial community within the human body consisting of trillions of microbes called gut microbiota. The normal flora is the site of many physiological functions such as enhancing the host immunity, participating in the nutrient absorption and protecting the body against pathogenic microorganisms. Numerous investigations showed a bidirectional interplay between gut microbiota and many organs within the human body such as the intestines, the lungs, the brain, and the skin. Large body of evidence demonstrated, more than a decade ago, that the gut microbial alteration is a key factor in the pathogenesis of many local and systemic disorders. In this regard, a deep understanding of the mechanisms involved in the gut microbial symbiosis/dysbiosis is crucial for the clinical and health field. We review the most recent studies on the involvement of gut microbiota in the pathogenesis of many diseases. We also elaborate the different strategies used to manipulate the gut microbiota in the prevention and treatment of disorders. The future of medicine is strongly related to the quality of our microbiota. Targeting microbiota dysbiosis will be a huge challenge.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Probióticos / Microbiota / Microbioma Gastrointestinal Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Probióticos / Microbiota / Microbioma Gastrointestinal Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article